Form 6-K TARO PHARMACEUTICAL INDU For: May 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Taro Pharma (TARO) Posts Inline Q4 Breakeven Loss
May 27, 2015 7:29 AM EDTTaro Pharma (NYSE: TARO) reported Q4 EPS of $0.00, versus $0.00 reported last year. Revenue for the quarter came in at $244.2 million, versus $881.79 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
... More